Daniel Faga - President, CEO, Director at First Tracks Biotherapeutics, Inc.

Issuer-level insider activity

Role
President, CEO, Director
Issuer ticker
TRAX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Daniel Faga since 12 Nov 2025

Reported holdings for Daniel Faga in First Tracks Biotherapeutics, Inc.

Form 4 holding President, CEO, Director

First Tracks Biotherapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
271,100
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO, Director

First Tracks Biotherapeutics, Inc.

Security class
Restricted Stock Unit
Shares / value
100,200
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Daniel Faga in First Tracks Biotherapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .